At the 300 mg dose of venetoclax the patient experienced side effects of severe neutropenia, (0.1 K/μL) requiring granulocyte-colony stimulating factor administration, as well as thrombocytopenia (100 K/μL). This evidence concerns the gene CSF3 and Thrombocytopenia.